Tyra Biosciences (TYRA) Non Operating Income (2020 - 2026)

Quarterly Non Operating Income fell 27.28% to $2.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $11.8 million through Mar 2026, down 31.74% year-over-year, with the annual reading at $12.8 million for FY2025, 27.58% down from the prior year.

Tyra Biosciences filings provide 7 years of Non Operating Income readings, the most recent being $2.7 million for Q1 2026.

  • Non Operating Income hit $2.7 million in Q1 2026 for Tyra Biosciences, roughly flat from $2.7 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $4.8 million in Q2 2024 and bottomed at $5000.0 in Q3 2022.
  • Average Non Operating Income over 5 years is $2.7 million, with a median of $2.8 million recorded in 2023.
  • The largest annual shift saw Non Operating Income soared 106050.0% in 2022 before it tumbled 35.73% in 2025.
  • Tyra Biosciences' Non Operating Income stood at $2.1 million in 2022, then surged by 32.08% to $2.8 million in 2023, then surged by 48.82% to $4.2 million in 2024, then tumbled by 35.73% to $2.7 million in 2025, then increased by 0.41% to $2.7 million in 2026.
  • Per Business Quant, the three most recent readings for TYRA's Non Operating Income are $2.7 million (Q1 2026), $2.7 million (Q4 2025), and $3.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 444,000.00
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 201.20 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn -46.98 Mn
10 Tyra Biosciences 2.03 Bn 2.03 Bn - 2.69 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.69 Mn
Dec 31, 2025 2.68 Mn
Sep 30, 2025 3.08 Mn
Jun 30, 2025 3.35 Mn
Mar 31, 2025 3.70 Mn
Dec 31, 2024 4.17 Mn
Sep 30, 2024 4.59 Mn
Jun 30, 2024 4.83 Mn
Mar 31, 2024 4.13 Mn
Dec 31, 2023 2.80 Mn
Sep 30, 2023 2.81 Mn
Jun 30, 2023 2.74 Mn
Mar 31, 2023 2.45 Mn
Dec 31, 2022 2.12 Mn
Sep 30, 2022 5,000.00
Jun 30, 2022 333,000.00
Mar 31, 2022 8,000.00
Dec 31, 2021 2,000.00
Sep 30, 2021 -5,000.00
Jun 30, 2021 -4,000.00
Mar 31, 2021 2,000.00
Dec 31, 2020 -8,000.00
Sep 30, 2020 -7,000.00